Uutiset-näyttösivun murupolku en
European Medicines Agency’s monitoring platform for shortages is now in use – training available for marketing authorisation holders
The European Medicines Agency (EMA) launched the European Shortages Monitoring Platform (ESMP) under its extended mandate in early February. Use of the ESMP is mandatory to all marketing authorisation holders and national competent authorities in all members states across the EU and the European Economic Area (EEA).
Following the EMA’s extended mandate, the ESMP is now a key tool and part in ensuring the availability of critical medicines during health emergencies and other preparedness actions led by EMA’s Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG). For this reason, use of the ESMP is mandatory for all marketing authorisation holders and national competent authorities in the EU and the EEA.
The use of a shared monitoring platform will promote harmonised reporting practices and result in more accurate, complete and timely information on the availability of medicines.
Public information on shortages of medicinal products is available in EMA’s shortages catalogue and in national shortages catalogues.
Training available for marketing authorisation holders on 19 February 2025
A training event will be held for marketing authorisation holders. The event will provide orientation especially on the reporting requirements during MSSG-led health emergency situations. The virtual training event will be held on 19 February 2025 from 10:00 to 12:30 (CET). A recording of the event will also be published afterwards. Registration for the event is already available on Webex and via the dedicated event page.